Michael S. Brown - Feb 23, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Director
Signature: /s/**Michael S. Brown
Stock symbol: REGN
Transactions as of: Feb 23, 2022
Transactions value $: -$304,340
Form type: 4
Date filed: 2/24/2022, 03:07 PM
Previous filing: Jan 5, 2022
Next filing: Mar 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Sale	-$304K	-500	-6.53%	$608.68	7.16K	Feb 23, 2022	by Trust
holding	REGN	Common Stock						1.08K	Feb 23, 2022	Direct
holding	REGN	Common Stock						5K	Feb 23, 2022	by SLAT	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.